Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
JCR Pharmaceuticals Co Ltd
4552Current price
679 JPY
0 JPY (0.00%)
Last closed
689 JPY
Company
www.jcrpharm.co.jp
ISIN
JP3701000006
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Tokyo Stock Exchange
Capitalization
85 065 039 365 JPY
Yield for 12 month
-43.37 %
1Y
3Y
5Y
10Y
15Y
4552
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices and laboratory instruments; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan. Address: 3-19 Kasuga-cho, Ashiya, Japan, 659-0021
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
135 931.93 JPYP/E ratio
–Dividend Yield
3.05 %Current Year
+42 796 830 086 JPY
Last Year
+34 283 584 099 JPY
Current Quarter
+8 130 908 521 JPY
Last Quarter
+9 137 164 578 JPY
Current Year
+31 196 933 460 JPY
Last Year
+25 412 957 528 JPY
Current Quarter
+5 847 865 304 JPY
Last Quarter
+5 945 695 758 JPY
Key Figures 4552
1 year
3 years
5 years
10 years
EBITDA
3 320 245 876 JPY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.12 %
PEG Ratio
–
Return On Equity TTM
-0.71 %
Wall Street Target Price
135 931.93 JPY
Revenue TTM
35 195 005 054 JPY
Book Value
452.09 JPY
Revenue Per Share TTM
Dividend Share
9.98 JPY
Quarterly Revenue Growth YOY
-36.8 %
Dividend Yield
3.05 %
Gross Profit TTM
40 550 722 701 JPY
Earnings per share
-3.52 JPY
Diluted Eps TTM
-3.52 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-87.5 %
Profit Margin
-1.24 %
Dividend Analytics 4552
Dividend growth over 5 years
196 %Continuous growth
2 yearsPayout Ratio 5 years average
43 %Dividend History 4552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
20
Ex Dividend Date
28.03.2025
Forward Annual Dividend Yield
2.95 %
Last Split Factor
4:1
Payout Ratio
5.49 %
Last Split Date
30.09.2020
Dividend Date
–
Stock Valuation 4552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
23.2558
Enterprise Value Revenue
2.5458
Price Sales TTM
2.417
Enterprise Value EBITDA
27.9964
Price Book MRQ
1.5169
Financials 4552
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4552
For 52 weeks
458.47 JPY
1 302.26 JPY
50 Day MA
654.05 JPY
Shares Short Prior Month
–
200 Day MA
732.03 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart